Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May;34 Suppl 2(Suppl 2):S231-5.
doi: 10.2337/dc11-s235.

Multidrug treatment of type 2 diabetes: a challenge for compliance

Affiliations

Multidrug treatment of type 2 diabetes: a challenge for compliance

Roberto Miccoli et al. Diabetes Care. 2011 May.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Unadjusted association between medication nonadherence (proportion of days covered <80%) and outcomes in 11,532 patients with diabetes. Adapted from Ho et al. (16).
Figure 2
Figure 2
Proportion of patients in specialist care and in exclusively primary care with drug regimen intensification in response to poor glycemic control (HbA1c >8%). Adapted from Shah et al. (28).

References

    1. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853 - PubMed
    1. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103–117 - PubMed
    1. ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;352004:739–743 - PubMed
    1. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129–139 - PubMed
    1. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545–2559 - PMC - PubMed

MeSH terms

Substances